TEMSIROLIMUS for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 11 adverse event reports in the FDA FAERS database where TEMSIROLIMUS was used for Prostate cancer.
Most Reported Side Effects for TEMSIROLIMUS
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Disease progression | 158 | 9.6% | 66 | 50 |
| Death | 136 | 8.3% | 135 | 14 |
| Stomatitis | 100 | 6.1% | 17 | 51 |
| Anaemia | 89 | 5.4% | 16 | 44 |
| Neoplasm progression | 84 | 5.1% | 33 | 24 |
| Vomiting | 81 | 4.9% | 13 | 52 |
| Diarrhoea | 79 | 4.8% | 9 | 51 |
| Febrile neutropenia | 78 | 4.7% | 1 | 66 |
| Pneumonia | 76 | 4.6% | 23 | 52 |
| Off label use | 75 | 4.6% | 15 | 12 |
| Fatigue | 74 | 4.5% | 15 | 25 |
| Pyrexia | 73 | 4.4% | 11 | 52 |
| Dehydration | 69 | 4.2% | 4 | 62 |
| Thrombocytopenia | 62 | 3.8% | 15 | 21 |
| Dyspnoea | 59 | 3.6% | 16 | 27 |
Other Indications for TEMSIROLIMUS
Renal cell carcinoma (213)
Metastatic renal cell carcinoma (131)
Embryonal rhabdomyosarcoma (121)
Product used for unknown indication (88)
Renal cancer (69)
Mantle cell lymphoma (65)
Neoplasm malignant (60)
Rhabdomyosarcoma (51)
Alveolar rhabdomyosarcoma (38)
Metastatic malignant melanoma (35)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
DEGARELIX (2,035)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)